These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9762237)

  • 1. Screening for colorectal cancer with Hemoccult-II in the average risk population.
    Kronborg O
    Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S44-8. PubMed ID: 9762237
    [No Abstract]   [Full Text] [Related]  

  • 2. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with screening for colorectal cancer in a population-based sample.
    Stamatakis KA; Simoes EJ; Brownson RC; Vradenburg J; Murayi T
    Mo Med; 2002 Jul; 99(7):279-85. PubMed ID: 12198998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of colorectal cancer screening.
    Hurst JS
    Am Fam Physician; 2003 Mar; 67(6):1188. PubMed ID: 12674445
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
    N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening and surveillance: the present and the future.
    Rex DK
    Rev Gastroenterol Disord; 2001; 1(1):18-31. PubMed ID: 12120116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J; Eichhorn C; Nagel E
    Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer: risk factors and recommendations for early detection.
    Read TE; Kodner IJ
    Am Fam Physician; 1999 Jun; 59(11):3083-92. PubMed ID: 10392591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colorectal cancer screening: an absolute necessity and an imminent reality in the French community].
    Polus M; Stibbe G; Van Laethem JL; Adler M; Coche E
    Rev Med Brux; 2009; 30(3):177-83. PubMed ID: 19642489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer test use among persons aged > or = 50 years--United States, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):193-6. PubMed ID: 12653456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current colorectal cancer screening strategies: overview and obstacles to implementation.
    Rex DK
    Rev Gastroenterol Disord; 2002; 2 Suppl 1():S2-11. PubMed ID: 12439393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated guidelines call for higher colorectal cancer screening rates.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Apr; 12(7):5-7. PubMed ID: 12075629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.